Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis

Infect Genet Evol. 2019 Dec:76:104003. doi: 10.1016/j.meegid.2019.104003. Epub 2019 Aug 16.

Abstract

Apoptosis is a universal cellular defense mechanism against senescent, damaged, genetically mutated, or virally-infected cells. It also is critical for the maintenance of liver health. Fas and FasL system act as a major death pathway that triggers apoptosis cascade in the liver. In this systematic review and meta-analysis, we aimed to investigate the relationship between four major polymorphisms of Fas and FasL genes with susceptibility to or clearance of HBV infection. All the eligible studies were extracted from PubMed and Scopus with no date and language restriction. ORs with 95% CIs were used to evaluate the strength of the association based on the following genetic models: (1) the allelic, (2) the homozygote, (3) the dominant, and (4) the recessive models. Totally 7 related articles were included in this meta-analysis; 5 studies of 7 related articles investigated FasL -844C/T (rs763110) polymorphism, 4 studies investigated FasL IVS2nt-124, 6 studies investigated Fas -670 A/G (rs1800682), and 4 studies investigated Fas -1377 A/G (rs2234767) polymorphism. This meta-analysis showed that there is no statistically significant association between the risk or clearance of HBV infection and four studied Fas and FasL polymorphisms in their allelic comparison or genetic models. Fas -670, Fas -1377, FasL -124, and FasL -844 polymorphisms did not show any significant association with the clearance or risk of HBV infection. Therefore, it seems that susceptibility to HBV infection or clearance of it is not affected by Fas and FasL genetic polymorphisms. But, to reach a definitive conclusion, further studies with a larger sample size of different ethnicity are still needed.

Keywords: Fas; FasL; HBV infection; Meta-analysis; Polymorphism.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Fas Ligand Protein / genetics*
  • Genetic Predisposition to Disease
  • Hepatitis B / genetics*
  • Hepatitis B / virology
  • Hepatitis B virus / isolation & purification
  • Homozygote
  • Humans
  • Odds Ratio
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic
  • fas Receptor / genetics*

Substances

  • FAS protein, human
  • FASLG protein, human
  • Fas Ligand Protein
  • fas Receptor